Proficio Capital Partners LLC Invests $1.04 Million in CVS Health Corporation $CVS

Proficio Capital Partners LLC bought a new position in shares of CVS Health Corporation (NYSE:CVS) in the second quarter, Holdings Channel reports. The firm bought 10,072 shares of the pharmacy operator’s stock, valued at approximately $1,042,000.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Caitong International Asset Management Co. Ltd grew its stake in shares of CVS Health by 407.2% in the third quarter. Caitong International Asset Management Co. Ltd now owns 350 shares of the pharmacy operator’s stock valued at $26,000 after buying an additional 281 shares in the last quarter. Swiss RE Ltd. acquired a new position in shares of CVS Health during the fourth quarter worth $26,000. Kilter Group LLC acquired a new stake in CVS Health during the 2nd quarter valued at $27,000. Sankala Group LLC acquired a new position in CVS Health in the 4th quarter worth $28,000. Finally, Global Trust Asset Management LLC grew its stake in shares of CVS Health by 344.8% during the first quarter. Global Trust Asset Management LLC now owns 387 shares of the pharmacy operator’s stock valued at $28,000 after acquiring an additional 300 shares in the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

CVS Health Price Performance

NYSE CVS opened at $94.22 on Thursday. The business’s fifty day moving average is $101.63 and its two-hundred day moving average is $89.33. CVS Health Corporation has a 1 year low of $69.51 and a 1 year high of $110.68. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.66 and a current ratio of 0.87. The stock has a market capitalization of $120.50 billion, a P/E ratio of 24.93, a P/E/G ratio of 0.84 and a beta of 0.61.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share for the quarter, beating analysts’ consensus estimates of $1.87 by $0.71. The business had revenue of $106.10 billion for the quarter, compared to the consensus estimate of $100.03 billion. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. CVS Health’s revenue for the quarter was up 7.3% on a year-over-year basis. During the same quarter last year, the firm earned $1.81 EPS. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. On average, research analysts forecast that CVS Health Corporation will post 8.02 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, August 3rd. Stockholders of record on Thursday, July 23rd were paid a $0.665 dividend. The ex-dividend date was Thursday, July 23rd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 2.8%. CVS Health’s payout ratio is presently 70.37%.

Analyst Ratings Changes

A number of equities research analysts have weighed in on the company. Truist Financial raised their price objective on CVS Health from $108.00 to $118.00 and gave the company a “buy” rating in a research note on Tuesday, July 14th. DA Davidson increased their target price on CVS Health from $80.00 to $100.00 and gave the company a “buy” rating in a research note on Thursday, May 7th. Argus lifted their price target on shares of CVS Health from $104.00 to $114.00 and gave the stock a “buy” rating in a research note on Wednesday, August 19th. Mizuho increased their price objective on shares of CVS Health from $110.00 to $115.00 and gave the company an “outperform” rating in a research note on Monday, June 8th. Finally, Piper Sandler reissued an “overweight” rating on shares of CVS Health in a report on Wednesday. Twenty-two analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, CVS Health has an average rating of “Moderate Buy” and an average price target of $107.17.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.